PCRF is proud to support Oncoheroes because our missions are deeply aligned. We believe that children deserve access to ...

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...

Study highlights importance of cancer driver biology in translating results from lab to patients -- -- Findings validate ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

Two formative experiences shaped Craig Crews’ path into drug development. First, when he was still a child, his grandmother died from cancer at just 52 years old. “At the time, there weren’t very many ...

Next-Gen Oncology Drugs Set New Standards in Cancer TreatmentThe Global Cancer/Oncology Drugs Market is valued at USD 183.4 Billion in 2025 and is projected to reach a value of USD 594.3 Billion by ...

The Delhi High Court allowed Indian pharma company Zydus Lifesciences to manufacture and sell a 'biosimilar' version of a ...

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...